• SAFB and Satellite RNAs: Phase Separation in Heterochromatin

  2026-05-20

  Huo et al. uncover how the nuclear matrix protein SAFB interacts with major satellite RNAs to stabilize pericentromeric heterochromatin through phase separation. This work delineates new molecular mechanisms that underpin 3D genome architecture, with implications for transcriptional regulation and chromatin biology.

• Preclinical Characterization of Anlotinib: A Potent VEGFR2 I

  2026-05-20

  This study provides a detailed preclinical evaluation of anlotinib hydrochloride, a highly potent and selective multi-target tyrosine kinase inhibitor focused on VEGFR2. The findings demonstrate its robust anti-angiogenic activity in vitro and in vivo, offering strong implications for angiogenesis-targeted cancer research and therapy development.

• Pioglitazone in Research: Optimizing PPARγ Agonist Workflows

  2026-05-19

  Pioglitazone, a selective PPARγ agonist, is redefining experimental strategies in metabolic and inflammatory disease research with robust, reproducible modulation of cellular and animal models. This article details actionable workflows, troubleshooting steps, and key innovations that empower researchers to maximize signal fidelity and translational relevance in PPARγ-driven studies.

• Applied Workflows for the 7-AAD Cell Viability Assay Kit

  2026-05-19

  The 7-AAD Cell Viability Assay Kit from APExBIO delivers multiplex-ready, highly specific detection of necrotic and late apoptotic cells, outperforming traditional viability assays in spectral flexibility. This article details experimental protocols, troubleshooting strategies, and bridges cutting-edge CAR-T research with practical cytometric analysis.

• Dissecting In Vitro Drug Response Metrics in Cancer Research

  2026-05-18

  Schwartz's dissertation redefines in vitro drug response evaluation in cancer by distinguishing between relative and fractional viability metrics. This work demonstrates that most anti-cancer agents simultaneously impact proliferation and cell death through distinct, non-interchangeable mechanisms, informing more accurate preclinical drug assessment.

• ARCA Cy3 EGFP mRNA (5-moUTP): Benchmarks & Biological Ration

  2026-05-18

  ARCA Cy3 EGFP mRNA (5-moUTP) is a 5-methoxyuridine modified, Cy3-labeled mRNA tool optimized for direct, quantitative imaging and robust mRNA transfection in mammalian cells. Its unique structure enables reduced innate immune activation and reproducible EGFP reporter gene expression. This article details its mechanism, evidence base, and integration into mRNA delivery workflows.

• Veratridine as a Voltage-Gated Sodium Channel Opener: Protoc

  2026-05-17

  Veratridine empowers precise control in sodium channel dynamics research, enabling advanced excitotoxicity and seizure modeling as well as chamber-specific cardiomyocyte studies. This guide translates breakthrough reference methodologies into actionable protocols, workflow refinements, and troubleshooting tips using APExBIO's high-purity Veratridine.

• TMRE Mitochondrial Membrane Potential Assay Kit: Applied Pre

  2026-05-16

  Accelerate mitochondrial function analysis and apoptosis research with the TMRE mitochondrial membrane potential assay kit. This APExBIO platform delivers robust, quantitative ΔΨm detection, supporting high-throughput workflows and advanced troubleshooting for translational research on sodium-driven mitochondrial dysfunction.

• Repurposing Lopinavir: Inhibiting MERS-CoV in Cell Culture

  2026-05-15

  de Wilde et al. systematically screened 348 FDA-approved drugs, identifying lopinavir as a low-micromolar inhibitor of MERS-CoV replication in vitro. This work demonstrates the value of drug repurposing for emerging coronaviruses and provides a foundation for future antiviral research and assay design.

• GOT1 Inhibition by Ziprasidone Alters PDAC Redox Metabolism

  2026-05-15

  Yang et al. (2022) demonstrate that ziprasidone acts as a non-competitive inhibitor of GOT1, disrupting glutamine metabolism and redox homeostasis in pancreatic ductal adenocarcinoma (PDAC) cells. Their findings highlight metabolic targeting via GOT1 inhibition as a promising direction for PDAC therapy, with implications for redox biology research.

• BCL-2 Family Inhibition Enhances mTORC1/2 Blockade in PIK3CA

  2026-05-14

  This study reveals that combining BCL-2 family inhibition with mTORC1/2 inhibitors significantly enhances apoptosis in PIK3CA-mutant colorectal cancer models. The findings identify BCL-xL as a key resistance determinant and provide a rationale for precision-guided co-targeting strategies to overcome treatment resistance.

• Norovirus Exploits NINJ1 for Selective Viral Protein Secreti

  2026-05-14

  This study uncovers how murine norovirus (MNoV) hijacks the host protein NINJ1 to enable selective secretion of its NS1 protein, revealing a new paradigm in virus-host interactions. The findings provide mechanistic insights into unconventional protein secretion during infection and highlight the regulated role of NINJ1 in membrane rupture.

• Trypsin (BA5744): Mechanistic Insights and Innovations in Wo

  2026-05-13

  Explore the mechanistic role of Trypsin as a serine protease in advanced wound healing and cell biology applications. This article delivers unique, evidence-driven analysis that bridges recent nanomaterial innovations with core biochemical principles.

• FLT3-TAZ Signaling Drives Drug Resistance in BP-CML: Insight

  2026-05-13

  Shin et al. (2023) establish FLT3 as a key driver of drug resistance in blast phase chronic myeloid leukemia (BP-CML), demonstrating that FLT3-JAK-STAT3-TAZ pathway activation confers resistance to BCR::ABL1 inhibitors. The study provides a mechanistic rationale for targeting FLT3 in BP-CML and highlights therapeutic opportunities for combining FLT3 inhibitors with existing TKIs.

• Bromodomain Inhibitor, (+)-JQ1: Advanced BET Assay Applicati

  2026-05-12

  APExBIO’s Bromodomain Inhibitor, (+)-JQ1 delivers precise, reproducible BET bromodomain inhibition for applications ranging from apoptosis assays to inflammation modulation and non-hormonal male contraception. This guide offers workflow upgrades, troubleshooting, and evidence-based protocols, drawing on the latest mechanistic insights to empower oncology, immunology, and epigenetics research.

14594 records 1/973 page Next 12345 下5页 Last page